GWM
TMDX icon

Geneos Wealth Management’s Transmedics TMDX Stock Holding History

Geneos Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531 Sell
8
-30,627
-100% -$2.59M ﹤0.01% 2471
2026
Q1 		$3.05M Buy
+30,635
New +$4M 0.07% 287
2024
Q4 		– Sell
-49
Closed -$7.69K – 2963
2024
Q3 		$7.69K Buy
+49
New +$7.55K ﹤0.01% 1928

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Geneos Wealth Management's TMDX Position: Q2 2026 in Review

Geneos Wealth Management reduced its Transmedics (TMDX) stake by 100% in Q2 2026, selling an estimated $2.59M and leaving 8 shares worth $531. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Geneos Wealth Management first reported a position in TMDX in Q3 2024 and has held it in 3 quarters since. The position peaked at $3.05M in Q1 2026. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Geneos Wealth Management held 8 shares of Transmedics worth $531 as of Q2 2026.
  • Geneos Wealth Management sold 30,627 Transmedics shares in Q2 2026, an estimated $2.59M.
  • Transmedics made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2471 holding.
  • Geneos Wealth Management first reported a position in Transmedics in Q3 2024 and has held it in 3 quarters since.
  • Geneos Wealth Management's Transmedics position peaked at $3.05M in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.